How Gilead Is Building Durable Oncology and Immunology Franchises

The Bio Report by Levine Media Group

Gilead today stands at an inflection point. Its HIV and broader virology business still account for roughly two-thirds of total revenue, even as oncology has grown into a mid–single-digit billion-dollar franchise and inf...View more